Complete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation

New England Journal of Medicine

Volumn 327, Issue 24, 1992, Pages 1729-1733

  Fay, William P ^a,d   Shapiro, Amy D ^b   Shih, Judy L ^a   Schleef, Raymond R ^c   Ginsburg, David ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Richard L Roudebush VA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BLEEDING DISORDER; CASE REPORT; CHILD; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FRAMESHIFT MUTATION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCHOOL CHILD;

BASE SEQUENCE; BLOOD PLATELETS; CASE REPORT; CHILD; FEMALE; FRAMESHIFT MUTATION; HUMAN; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026448949     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199212103272406     Document Type: Article

References (28)

1. Vassalli J-D, Sappino A-P, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88: 1067–72.
2. Loskutoff DJ, Sawdey M, Mimuro J. Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 1989; 9: 87–115.
3. Erickson LA, Hekman CM, Loskutoff DJ. The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. Proc Natl Acad Sci U S A 1985; 82: 8710–4.
4. Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J Clin Invest 1991; 88: 1346–53.
5. Wiman B, Ljungberg B, Chmielewska J, Urden G, Blomback M, Johnsson H. The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med 1985; 105: 265–70.
6. Hamsten A, Wiman B, de Faire U, Blombåck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557–63.
7. Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 1990; 346: 74–6.
8. Montesano R, Pepper MS, Möhle-Steinlein U, Risau W, Wagner EF, Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 1990; 62: 435–45.
9. Liu Y-X, Peng X-R, Ny T. Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation. Eur J Biochem 1991; 195: 549–55.
10. Sordat B, Reiter L, Cajot J-F. Modulation of the malignant phenotype with the urokinase-type plasminogen activator and the type I plasminogen activator inhibitor. Cell Differ Dev 1990; 32: 277–85.
11. Carrell RW, Aulak KS, Owen MC. The molecular pathology of the serpins. Mol Biol Med 1989; 6: 35–42.
12. Schleef RR, Higgins DL, Pillemer E, Levitt LJ. Bleeding diathesis due to decreased functional activity of Type 1 plasminogen activator inhibitor. J Clin Invest 1989; 83: 1747–52.
13. Diéval J, Nguyen G, Gross S, Delobel J, Kruithof EKO. A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood 1991; 77: 528–32.
14. Ginsburg D, Konkle BA, Gill JC, et al. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. Proc Natl Acad Sci U S A 1989; 86: 3723–7.
15. Schleef RR, Sinha M, Loskutoff DJ. Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator. J Lab Clin Med 1985; 106: 408–15.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989.
17. Ginsburg D, Zeheb R, Yang AY, et al. cDNA cloning of human plasminogen activator—inhibitor from endothelial cells. J Clin Invest 1986; 78: 1673–80.
18. Gyllensten UB, Erlich HA. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A 1988; 85: 7652–6.
19. Cooney KA, Nichols WC, Brack ME, et al. The molecular defect in Type IIB von Willebrand disease: identification of four potential missense mutations within the putative GpIb binding domain. J Clin Invest 1991; 87: 1227–33.
20. Hanson CA, Holbrook EA, Sheldon S, Schnitzer B, Roth MS. Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction. Am J Pathol 1990; 137: 1–6.
21. Sherman PM, Lawrence DA, Yang AY, et al. Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center. J Biol Chem 1992; 267: 7588–95.
22. Bosma PJ, van den Berg EA, Kooistra T, Siemieniak DR, Slightom JL. Human plasminogen activator inhibitor-1 gene: promoter and structural gene nucleotide sequences. J Biol Chem 1988; 263: 9129–41.
23. Schlötterer C, Tautz D. Slippage synthesis of simple sequence DNA. Nucleic Acids Res 1992; 20: 211–5.
24. Roth MS, Antin JH, Bingham EL, Ginsburg D. Use of polymerase chain reaction-detected sequence polymorphisms to document engraftment following allogeneic bone marrow transplantation. Transplantation 1990; 49: 714–20.
25. Cheng J, Fogel-Petrovic M, Maquat LE. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol Cell Biol 1990; 10: 5215–25.
26. Brodbeck RM, Brown JL. Secretion of α1-proteinase inhibitor requires an almost full length molecule. J Biol Chem 1992; 267: 294–7.
27. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1991; 11: 183–90.
28. Capecchi MR. Altering the genome by homologous recombination. Science 1989; 244: 1288–92.